Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects

American Journal of Physiology - Endocrinology and Metabolism

Volumn 270, Issue 2 33-2, 1996, Pages

  Boden, Guenther ^a,b   Ruiz, Jose ^a   Kim, Cherng Ju ^a   Chen, Xinhua ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

hyperglycemic clamping; plasma C peptide; prehepatic insulin secretion

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN METABOLISM; INSULIN RELEASE; MALE; NORMAL HUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0029880428     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.270.2.e251     Document Type: Article

References (32)

1. Boden, G., F. Jadali, J. White, Y. Liang, M. Mozzoli, X. Chen, E. Coleman, and C. Smith. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J. Clin. Invest. 88: 960-966, 1991.
2. Boden, G., T. K. Ray, R. H. Smith, and O. E. Owen. Carbohydrate oxidation and storage in obese non-insulin-dependent diabetic patients. Diabetes 32: 982-987, 1983.
3. Bonner-Weir, S., D. F. Trent, R. N. Honey, and G. C. Weir. Responses of neonatal rat islets to streptozotocin. Limited β-cell regeneration and hyperglycemia. Diabetes 30: 64-69, 1981.
4. Byrne, M. M., J. Sturis, and K. S. Polonsky. Insulin secretion and clearance during low-dose graded glucose infusion. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E21-E27, 1995.
5. Desbuquois, B., and G. D. Aurbach. Use of polyethylene glycol to separate free and antibody bound peptide hormones in radio-immunoassays. J. Clin. Endocrinol. Metab. 33: 732-738, 1971.
6. Duckworth, W. C. Insulin degradation: mechanisms, products, and significance. Endocr. Rev. 9: 319-345, 1988.
7. Eizirik, D. L., G. S. Korbutt, and C. Hellerstrom. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the β-cell function. J. Clin. Invest. 90: 1263-1268, 1992.
8. Flax, H., D. R. Matthews, J. C. Levy, S. W. Coppack, and R. C. Turner. No glucotoxicity after 53 hours of 6.0 mmol/l hyperglycemia in normal man. Diabetologia 34: 570-575, 1991.
9. Gumbiner, B., K. S. Polonsky, W. F. Beltz, K. Griver, P. Wallace, G. Brechtel, and R. R. Henry. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 70: 1594-1602, 1990.
10. Kahn, S. E., R. N. Bergman, M. W. Schwartz, G. J. Taborsky, Jr., and D. Porte, Jr. Short-term hyperglycemia and hyperinsulinemia improve insulin action but do not alter glucose action in normal humans. Am. J. Physiol. 262 (Endocrinol. Metab. 25): E518-E523, 1992.
11. Kosaka, K., T. Kuzuya, Y. Akanuma, and R. Hagura. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia 18: 23-28, 1980.
12. Laury, M. C., F. Takao, D. Bailbe, L. Penicaud, B. Portha, L. Picon, and A. Ktorza. Differential effects of prolonged hyperglycemia on in vivo and in vitro insulin secretion in rats. Endocrinology 128: 2526-2533, 1991.
13. Leahy, J. L., S. Bonner-Weir, and G. C. Weir. β-Cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 15: 442-455, 1992.
14. Leahy, J. L., H. E. Cooper, D. A. Deal, and G. C. Weir. Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. J. Clin. Invest. 77: 908-915, 1986.
15. Marshall, S., V. Bacote, and R. R. Traxinger. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. J. Biol. Chem. 266: 4706-4712, 1991.
16. Molina, J. M., A. D. Baron, S. V. Edelman, G. Brechtel, P. Wallace, and J. M. Olefsky. Use of a variable tracer infusion method to determine glucose turnover in humans. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E16-E23, 1990.
17. Polonsky, K. S., J. Licinio-Paixao, B. D. Given, W. Pugh, P. Rue, J. Galloway, T. Karrison, and B. Frank. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type 1 diabetic patients. J. Clin. Invest. 77: 98-105, 1986.
18. Porte, D., and A. A. Pupo. Insulin responses to glucose: evidence for a two pool system in man. J. Clin. Invest. 48: 2309-2319, 1969.
19. Rizza, R. A., L. J. Mandarino, J. Genest, B. A. Baker, and J. E. Gerich, Production of insulin resistance by hyperinsulinaemia in man. Diabetologia 28: 70-75, 1985.
20. Rossetti, L., A. Giaccari, and R. A. DeFronzo. Glucose toxicity. Diabetes Care 13: 610-630, 1990.
21. Rossetti, L., G. I. Shulman, W. Zawalich, and R. A. DeFronzo. Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J. Clin. Invest. 80: 1037-1044, 1987.
22. Rossetti, L., D. Smith, G. I. Shulman, D. Papachristou, and R. A. DeFronzo. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Invest. 79: 1510-1515, 1987.
23. Service, F. J., R. L. Nelson, A. H. Rubenstein, and V. L. W. Go. Direct effect of insulin on secretion of insulin, glucagon, gastric inhibitory polypeptide, and gastrin during maintenance of normoglycemia. J. Clin. Endocrinol. Metab. 47: 488-493, 1978.
24. Steele, R., J. S. Wall, R. C. DeBodo, and N. Altszuler. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am. J. Physiol. 187: 15-24, 1956.
25. Thibault, C., C. Guettet, M. C. Laury, J. M. N'Guyen, M. A. Tormo, D. Bailbe, B. Portha, L. Penicaud, and A. Ktorza. In vivo and in vitro increased pancreatic beta-cell sensitivity to glucose in normal rats submitted to a 48-h hyperglycaemic period. Diabetologia 36: 589-595, 1993.
26. Tillil, H., E. T. Shapiro, M. A. Miller, T. Karrison, B. H. Frank, J. A. Galloway, A. H. Rubenstein, and K. S. Polon-sky. Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans. Am. J. Physiol. 254:(Endocrinol. Metab. 17): E349-E357, 1988.
27. Tranberg, K.-G. Hepatic uptake of insulin in man. Am. J. Physiol. 237 (Endocrinol. Metab. Gastrointest. Physiol. 6): E509-E518, 1979.
28. Traxinger, R. R., and S. Marshall. Recovery of maximal insulin responsiveness and insulin sensitivity after induction of insulin resistance in primary cultured adipocytes. J. Biol. Chem. 264: 8156-8163, 1989.
29. Van Cauter, E., F. Mestrez, J. Sturis, and K. S. Polonsky. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41: 368-377, 1992.
30. Vuorinen-Markkola, H., V. A. Koivisto, and H. Yki-Jarvinen. Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type 1 diabetic patients. Diabetes 41: 571-580, 1992.
31. Ward, W. K., J. B. Halter, J. C. Beard, and D. Porte, Jr. Adaptation of B and A cell function during prolonged glucose infusion in human subjects. Am. J. Physiol. 246 (Endocrinol. Metab. 9): E405-E411, 1984.
32. Yki-Jarvinen, H. Glucose toxicity. Endocr. Rev. 13: 415-431, 1992.